IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) — Stock Price

Rs164.66 INR
▼ -1.90% today

IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) is currently trading at Rs164.66 INR, down 1.90% today. Over the past 52 weeks, shares have ranged between Rs68.21 and Rs173.78. This page tracks IOL Chemicals and Pharmaceuticals Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see IOL Chemicals and Pharmaceuticals Limite (IOLCP) market capitalisation.

IOL Chemicals and Pharmaceuticals Limited (IOLCP) Stock Price Chart — Daily History & Trading Volume

The chart below tracks IOL Chemicals and Pharmaceuticals Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

IOL Chemicals and Pharmaceuticals Limited Income Statement — Revenue, Profit & Earnings by Year

IOL Chemicals and Pharmaceuticals Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs23.19 Billion Rs20.68 Billion Rs21.19 Billion Rs22.02 Billion Rs21.84 Billion
Cost of Revenue Rs18.16 Billion Rs14.14 Billion Rs14.18 Billion Rs15.61 Billion Rs18.70 Billion
Gross Profit Rs5.03 Billion Rs6.54 Billion Rs2.70 Billion Rs6.41 Billion Rs5.72 Billion
Research & Development — Rs167.50 Million Rs173.70 Million Rs167.50 Million Rs111.40 Million
SG&A — Rs56.50 Million Rs66.90 Million Rs58.30 Million Rs45.00 Million
Total Operating Expenses Rs3.15 Billion Rs1.10 Billion Rs1.10 Billion Rs1.85 Billion Rs983.50 Million
Operating Income Rs1.89 Billion Rs1.24 Billion Rs1.60 Billion Rs1.74 Billion Rs2.16 Billion
EBITDA Rs2.69 Billion Rs2.25 Billion Rs2.61 Billion Rs2.46 Billion Rs2.71 Billion
EBIT Rs1.89 Billion Rs1.53 Billion Rs1.98 Billion Rs1.99 Billion Rs2.27 Billion
Interest Expense Rs145.50 Million Rs147.60 Million Rs161.00 Million Rs164.70 Million Rs82.90 Million
Income Before Tax Rs1.84 Billion Rs1.38 Billion Rs1.82 Billion Rs1.89 Billion Rs2.25 Billion
Income Tax Expense Rs467.20 Million Rs368.90 Million Rs472.20 Million Rs495.10 Million Rs571.80 Million
Net Income Rs1.38 Billion Rs1.01 Billion Rs1.34 Billion Rs1.39 Billion Rs1.68 Billion

IOL Chemicals and Pharmaceuticals Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes IOL Chemicals and Pharmaceuticals Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs25.87 Billion Rs23.82 Billion Rs22.44 Billion Rs20.22 Billion Rs19.62 Billion
Total Current Assets Rs12.28 Billion Rs11.51 Billion Rs11.20 Billion Rs9.20 Billion Rs10.81 Billion
Cash & Equivalents — — — — Rs0.00
Short-term Investments Rs35.10 Million Rs1.31 Billion Rs1.35 Billion Rs217.50 Million Rs1.17 Billion
Net Receivables Rs6.03 Billion Rs5.34 Billion Rs4.83 Billion Rs5.27 Billion Rs4.92 Billion
Inventory Rs3.71 Billion Rs3.61 Billion Rs4.25 Billion Rs3.26 Billion Rs4.10 Billion
Property, Plant & Equipment — Rs11.79 Billion Rs10.21 Billion Rs8.33 Billion Rs6.62 Billion
Goodwill — — — — —
Total Liabilities Rs7.88 Billion Rs6.94 Billion Rs6.33 Billion Rs5.14 Billion Rs5.70 Billion
Total Current Liabilities Rs6.90 Billion Rs6.10 Billion Rs5.60 Billion Rs4.56 Billion Rs5.13 Billion
Long-term Debt Rs0.00 Rs0.00 Rs0.00 Rs0.00 Rs0.00
Net Debt Rs-629.40 Million Rs388.70 Million Rs250.70 Million Rs784.20 Million Rs407.20 Million
Total Stockholder Equity Rs17.99 Billion Rs16.88 Billion Rs16.12 Billion Rs15.08 Billion Rs13.92 Billion
Retained Earnings — Rs14.02 Billion Rs13.24 Billion Rs12.19 Billion Rs11.04 Billion

IOL Chemicals and Pharmaceuticals Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how IOL Chemicals and Pharmaceuticals Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs2.11 Billion Rs1.79 Billion Rs2.90 Billion Rs1.22 Billion Rs930.50 Million
Capital Expenditures Rs1.73 Billion Rs2.14 Billion Rs2.74 Billion Rs2.12 Billion Rs1.53 Billion
Free Cash Flow Rs384.30 Million Rs-349.30 Million Rs159.10 Million Rs-895.50 Million Rs-602.40 Million
Investing Cash Flow Rs-2.10 Billion Rs-1.54 Billion Rs-1.91 Billion Rs-1.20 Billion Rs-1.20 Billion
Financing Cash Flow Rs-145.00 Million Rs460.40 Million Rs-925.00 Million Rs-41.10 Million Rs-16.40 Million
Dividends Paid Rs293.50 Million Rs234.80 Million Rs293.50 Million Rs235.00 Million Rs352.20 Million
Stock-Based Compensation — — — — —
Depreciation Rs802.30 Million Rs719.90 Million Rs629.10 Million Rs461.60 Million Rs432.60 Million
Change in Cash Rs1.18 Billion Rs704.80 Million Rs63.00 Million Rs-18.40 Million Rs-287.80 Million

IOL Chemicals and Pharmaceuticals Limited Earnings History — EPS Actual vs. Analyst Estimates

Track IOL Chemicals and Pharmaceuticals Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 14, 2026 — — —
Feb 10, 2026 — — —
Nov 12, 2025 — — —
Aug 07, 2025 — — —
May 16, 2025 — — —
Feb 04, 2025 — — —
Nov 06, 2024 — — —
May 14, 2024 5.07 8.40 -39.64%